Empower Hour - Development of Therapeutics that Target Malfunctioning Messengers

Wednesday, November 18, 2020 1:00pm to 2:00pm

Add to calendar

The Ohio University Alumni Association is excited to introduce you to the next installment in our virtual series, Empower Hour! This event takes place every other Wednesday from 1-2 p.m. EST.


Empower Hour is a program that explores important and relevant topics centered around the theme of continued personal growth and education. We want to equip OHIO alumni with the knowledge they need to become their best selves!


This Empower Hour segment is called "Development of Therapeutics that Target Malfunctioning Messengers.” The cells that make up your body have an elegant and highly sophisticated communication network. This network allows your body to respond to invading pathogens such as bacteria and viruses. But when a messenger within the network starts to malfunction, a variety of pathological conditions can arise. These include cytokine storms which appear to be a significant complication of COVID-19. Join Doug Goetz for our Empower Hour as he shares his team’s efforts to target the malfunctioning messengers as a means to generate new therapeutics for disease.


This hour will highlight:
     - How the cells in your body communicate
     - How your body uses this communication network to respond to invasion by bacteria and viruses
     - How malfunctioning messengers in the communication network cause problems in COVID-19
     - Efforts to develop therapeutics that target malfunctioning messengers


Dr Douglas Goetz.jpg


Dr. Douglas J. Goetz is a Professor of Chemical and Biomolecular Engineering and the Director of the MS in Biomedical Engineering Program at Ohio University. He holds a Ph.D. in Chemical Engineering from Cornell University, a M.S. in Chemical Engineering, and a B.S. in Chemistry both from Purdue University. Prior to coming to Ohio University, he was an Assistant Professor of Biomedical Engineering at The University of Memphis. Between his Ph.D. and his position at Memphis, Dr. Goetz was a Post-doctoral Research Fellow at The Brigham and Women’s Hospital/Harvard Medical School. This past year he was elected as a fellow to the American Institute for Medical and Biological Engineering. His research seeks to further our understanding of the molecular mechanisms of disease and exploit this understanding to suggest novel therapeutics and diagnostics. 



You will receive a confirmation email upon registration that will include details on how to join this virtual event.


If you have any questions, please email Associate Director, Alumni Experiences, Caleb Beasecker at beasecker@ohio.edu.

Event Details

0 people are interested in this event

User Activity

No recent activity